David Plante, MD, PhD, Chair
Dr. Plante is Associate Professor of Psychiatry at the University of Wisconsin School of Medicine and Public Health. He is a Fellow of the American Academy of Sleep Medicine, member of the Sleep Research Society, and Program Director for the University of Wisconsin Sleep Medicine Fellowship. His current research uses high-density electroencephalography to study sleep and wakefulness in hypersomnia and affective disorders.
Isabelle Arnulf, MD, PhD
Having authored more than 150 publications in peer-reviewed scientific journals, Professor Arnulf is not only one of the world’s leading experts on all forms of hypersomnia, including narcolepsy, idiopathic hypersomnia, and Kleine-Levin syndrome, but also Professor of Neurology at the Sorbonne Universités, Pierre and Marie Curie University, and head of the Sleep Disorder Service at the Pitié-Salpêtrière University Hospital in Paris, France. She trained with Dr. Michel Jouvet, who studied the function and mechanism of REM sleep soon after its discovery, and completed a postdoctoral fellowship with Dr. Emmanuel Mignot at Stanford University. Dr. Arnulf is the past-president of the French Sleep Society.
Ana Krieger, MD
Dr. Krieger is Associate Professor of Clinical Medicine in the Departments of Medicine, Neurology, and Genetic Medicine at Weill Cornell Medical College. She is board certified in sleep medicine and the Medical Director of the Weill Cornell Center for Sleep Medicine. Dr. Krieger also holds board certification in internal medicine and pulmonary medicine and is a faculty member in the Division of Pulmonary and Critical Care Medicine, Department of Medicine, at Weill Cornell Medical College and an Associate Attending at the New York Presbyterian Hospital/Weill Cornell Medical Center and at Rockefeller University Hospital.
Over the past 17 years, Dr. Krieger has been actively involved in clinical care and education, training sleep specialists, and conducting collaborative multidisciplinary research projects in sleep medicine. She serves as the Chair of the Sleep Deprivation Committee of the American Academy of Sleep Medicine and the President of the Northeast Sleep Society. Dr. Krieger is a Robert Wood Johnson Scholar, a Fellow of the Royal Society of Medicine, and a Fellow and Policy Advisor at the New York Academy of Medicine. She regularly contributes to media efforts aiming at achieving public awareness of sleep problems and a better understanding of their multifaceted consequences and treatment alternatives.
Gert Jan Lammers, MD, PhD
Dr. Lammers trained as a neurologist and clinical neurophysiologist at Leiden University Medical Center, then earned a PhD at Leiden University with a thesis titled "Narcolepsy." He is currently a professor of neurology at Leiden University, and the primary focus of his research is on narcolepsy and related disorders of hypersomnolence. Dr. Lammers is one of the founding members of the European Narcolepsy Network, which is an organization of clinicians and researchers across all of Europe with a focus on central disorders of hypersomnolence in general, and he served as President of the organization from 2007-2014. In 2013, he obtained the qualification of Somnologist from the European Sleep Research Society, and he was appointed as fellow of the European Neurological Association in 2021. After founding a new sleep/wake center in 2013, he became the Medical Director of all three sleep/wake centers of SEIN, which is the Dutch center of excellence for epilepsy and sleep disorders. Dr. Lammers is the current chair of the Dutch Society for Sleep Medicine. He has published extensively (more than 180 PubMed cited papers), including on diagnostic criteria and pharmacological treatment of idiopathic hypersomnia.
Kiran Maski, MD, MPH
Kiran Maski, MD, MPH, is an assistant professor at Harvard Medical School and a child neurologist and sleep medicine specialist at Boston Children’s Hospital. She received her medical degree from the University of Wisconsin and completed her general pediatric residency at Tufts-New England Medical Center. She received her pediatric neurology residency and pediatric sleep fellowship training at Boston Children’s Hospital (BCH). She now runs the Neurology Sleep Clinic at BCH and is the assistant program director for the Child Neurology Residency. Dr. Maski’s clinical work and research is focused on pediatric narcolepsy. Dr. Maski has created a hypersomnia clinic at BCH where she sees children and young adults with central nervous system hypersomnia conditions from all over the world. She is an advocate for pediatric narcolepsy, promoting awareness of this condition among health care providers and schools. She was honored with the “Outstanding Physician” award by Wake Up Narcolepsy, a patient advocacy group, for this work in 2015. Dr. Maski currently serves as the Chairperson of the American Academy of Sleep Medicine Task Force for the Treatment of Central Nervous System Hypersomnias. Her clinical research in narcolepsy is focused on neurophysiological biomarkers that help diagnose and treat narcolepsy patients. She has received grant support from the American Academy of Neurology, American Sleep Medicine Foundation, Wake Up Narcolepsy, BCH Research Council Fund, and Jazz Pharmceuticals, Inc.
Jason Ong, PhD, DBSM
Dr. Ong is the Director of Behavioral Sleep Medicine at Nox Health and an Adjunct Associate Professor of Neurology at Northwestern University Feinberg School of Medicine. He received his PhD in clinical psychology from Virginia Commonwealth University and completed a fellowship in Behavioral Sleep Medicine at Stanford University Medical Center. His research interest involves demonstrating the effectiveness and value of behavioral treatments for sleep disorders, including cognitive-behavioral therapy and mindfulness meditation. Related to hypersomnias, Dr. Ong is involved in studies examining the psychosocial impact of hypersomnias and behavioral interventions to improve quality of life in people with hypersomnias.
Chad Ruoff, MD
Dr. Ruoff is a Senior Associate Consultant in sleep medicine at the Mayo Clinic Arizona. He is board certified in sleep medicine, obesity medicine, and internal medicine. Dr. Ruoff’s career in sleep medicine began as a sleep technologist in 1998, while completing his undergraduate education at Georgetown University. He received his internal medicine training at Baylor College of Medicine and then completed a sleep medicine fellowship at Stanford University in 2011, after which he joined the Stanford sleep faculty. Later, he spent a few years practicing sleep and obesity medicine at Kaiser in Woodland Hills, CA, before moving on to Mayo in 2020. He has developed a strong interest in the clinical evaluation and treatment of CNS hypersomnias, and is active in research and on AASM task forces.
Mandeep Singh, MBBS, MD, MSc, FRCPC
Dr. Singh completed his Anesthesiology training at the University of Toronto, and later completed his Sleep Medicine fellowship training at the University of Toronto. He has the distinction of being the first Canadian physician to be dual-specialized in Sleep Medicine and Anesthesiology. He also completed a Masters in Clinical Epidemiology and Health Sciences Research from the University of Toronto.
His current research interests include evaluating the perioperative (before and after surgery) outcomes in patients with sleep disorders, including disorders of daytime hypersomnolence. Dr. Singh is one of the authors of an article published last year about the anesthesia concerns for patients with idiopathic hypersomnia (IH) who are considering surgery.
Lynn Marie Trotti, MD, MSc
Dr. Trotti is Associate Professor of Neurology at Emory University in Atlanta, GA. She graduated from Baylor College of Medicine and completed her neurology residency, sleep fellowship, and Masters of Science in Clinical Research at Emory. Her main area of clinical and research interest is the central disorders of hypersomnolence. Dr. Trotti is currently funded by the National Institutes of Health and the American Academy of Sleep Medicine Foundation as the principal investigator of two clinical trials investigating treatments for hypersomnolence. She is the recipient of the Hypersomnia Foundation's 2020 Impact Award. In bestowing this award, the Foundation noted her outstanding and ongoing contributions to IH research, her exceptional care of her patients, and her multiple advocacy and education efforts as Chair of the Foundation's Medical Advisory Board from its inception in 2014 through 2020.